BRIEF published on 01/05/2026 at 20:35, 7 months 13 days ago La Banque Cantonale de Zurich dévoile sa position dans Avadel Pharmaceuticals Formulaire 8.3 Banque Cantonale De Zurich Titres Détenus Avadel Pharmaceuticals Panel Irlandais Des OPA
PRESS RELEASE published on 01/05/2026 at 20:30, 7 months 13 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed a 1.02% interest in Avadel Pharmaceuticals plc shares on 2nd January 2026 Shares Disclosure Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 17:05, 7 months 13 days ago La Banque Cantonale de Zurich dévoile sa position dans Avadel Pharmaceuticals Formulaire 8.3 Banque Cantonale De Zurich Information Sur Les Valeurs Mobilières Avadel Pharmaceuticals Panel Irlandais Des OPA
BRIEF published on 01/05/2026 at 17:05, 7 months 13 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 17:00, 7 months 13 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.02% position in Avadel Pharmaceuticals plc as of 31st December 2025 following dealing activities Position Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc 1.02% Dealing Activities
BRIEF published on 11/20/2025 at 16:05, 8 months 28 days ago La Banque Cantonale de Zurich dévoile sa position dans Avadel Pharmaceuticals Actions Ordinaires Formulaire 8.3 Banque Cantonale De Zurich Avadel Pharmaceuticals Information Sur L'OPA
BRIEF published on 11/20/2025 at 16:05, 8 months 28 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Form 8.3 Zürcher Kantonalbank Takeover Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/20/2025 at 16:00, 8 months 28 days ago Form 8.3 - Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose 0.04% interest in Avadel Pharmaceuticals plc as of 19th November 2025. No other party involved. No dealings reported Disclosure Dealings Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 11/19/2025 at 16:20, 8 months 29 days ago Divulgation de la Banque Cantonale de Zurich concernant Avadel Pharmaceuticals plc Divulgation Banque Cantonale De Zurich Intérêts En Valeurs Mobilières Avadel Pharmaceuticals Panel Irlandais Des OPA
BRIEF published on 11/19/2025 at 16:20, 8 months 29 days ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals plc Disclosure Irish Takeover Panel Zürcher Kantonalbank Securities Interests Avadel Pharmaceuticals
Published on 08/18/2026 at 23:10, 4 hours 23 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 7 hours 48 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 9 hours 3 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 9 hours 53 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 17:00, 10 hours 33 minutes ago Galaxy Ventures Inc.: TruSilver Deepens 1960s Holes to 712 Metres, Logs Sulphides Next to Past-Producing Walton Silver Mine
Published on 08/18/2026 at 22:00, 5 hours 33 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 5 hours 42 minutes ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 8 hours 33 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 8 hours 48 minutes ago Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 9 hours 22 minutes ago Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD
Published on 08/18/2026 at 18:00, 9 hours 33 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 9 hours 48 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 16 hours 17 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 16 hours 17 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 7 hours ago Aéroports de Paris S.A - July 2026 traffic figures
